Conformational Landscape of the HIV-1 Envelope Glycoproteins
HIV-1 包膜糖蛋白的构象景观
基本信息
- 批准号:10594418
- 负责人:
- 金额:$ 63.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAmino AcidsAntibodiesAntibody ResponseBindingBiologicalCCR5 geneCD4 Positive T LymphocytesCXCR4 geneCell membraneCell surfaceCellsCompensationComplementCytoplasmic TailDetergentsDiseaseElementsEnvironmentExhibitsExposure toFundingGenetic PolymorphismGlycoproteinsGoalsGrantHIVHIV Envelope Protein gp120HIV envelope proteinImmune EvasionImmune systemMaintenanceMass Spectrum AnalysisMediatingMembraneMembrane FusionMolecular ConformationMolecular MachinesNaturePhenotypePredispositionProcessPropertyRegulationResearchResistanceRestSamplingShapesStructureSurfaceTestingThermodynamicsTropismVaccinationVaccinesViralVirionVirusVirus DiseasesWorkconformational conversioncrosslinkdesignflexibilityglycoprotein structureglycosylationimmunogenicityinhibitorinterestmutantneutralizing antibodynovelprototypereceptorrestraintsmall moleculesmall molecule inhibitortherapy designvirus envelope
项目摘要
PROJECT SUMMARY/ABSTRACT
The entry of human immunodeficiency virus (HIV-1) into host cells is mediated by the envelope glycoprotein
(Env) trimer. The Env trimer consists of three gp120 exterior glycoproteins non-covalently associated with
three gp41 glycoproteins, which are anchored in the viral membrane and which possess long (~145-residue)
cytoplasmic tails. As the only virus-specific molecule on the viral surface, Env is the major target for host
neutralizing antibodies. Env conformational flexibility is essential for virus entry and also contributes to the
ability of HIV-1 to evade the host antibody response. During virus entry, the binding of gp120 to the receptors,
CD4 and CCR5/CXCR4, triggers conformational changes in the metastable Env that ultimately result in gp41-
mediated fusion of the viral and target cell membranes. The HIV-1 Env on virions potentially samples at least
three conformations: a “closed” pretriggered conformation (State 1), an “open” CD4-bound conformation (State
3), and an intermediate “partially open” conformation (State 2). Prior to receptor engagement, the State-1 Env
conformation is energetically favored, rendering primary HIV-1 strains relatively resistant to the binding of
potentially neutralizing antibodies. CD4 binding drives Env from State 1 to State 2 and then into State 3, the
prehairpin intermediate. Binding of the State-3 Env to the CCR5 or CXCR4 coreceptor promotes the formation
of the highly stable gp41 six-helix bundle, resulting in the fusion of the viral and target cell membranes.
Multiple observations indicate that the State-1 Env conformation is metastable and easily disrupted by
alteration of Env sequences or extraction of Env from a membrane environment. Indeed, stabilized soluble
gp140 trimers or detergent-solubilized Env trimers for which detailed structures are available have been shown
to adopt a State-2-like conformation! The proposed work will address our currently incomplete understanding
of the State-1 Env conformation. How does HIV-1, despite its tremendous variability, maintain a State-1 Env
conformation? We have previously shown that changes in multiple Env amino acid residues can disrupt the
State-1 conformation. In the proposed studies, we will identify naturally polymorphic Env residues that, when
changed, stabilize the functional State-1 conformation. We will evaluate how State-1-stabilizing and State-1-
destabilizing changes in Env interact to determine viral phenotypes. One focus of these studies will be the
relationship between the conformation of the gp41 membrane-proximal external region (MPER) and the
conformation of the rest of the Env ectodomain.
The metastability of the State-1 Env conformation impedes its presentation to the host immune system during
natural HIV-1 infection and following vaccination. The proposed studies will inform efforts to produce purified
HIV-1 Env trimers stabilized in a State-1 conformation, which serves as the major target of broadly neutralizing
antibodies and potent small-molecule entry inhibitors. Understanding how the State-1 Env conformation is
regulated should expedite the design of Env-directed therapies and vaccines.
项目总结/摘要
人类免疫缺陷病毒(HIV-1)进入宿主细胞是由包膜糖蛋白介导的
(Env)三聚体。Env三聚体由三个gp 120外部糖蛋白组成,所述糖蛋白与
三种gp 41糖蛋白,锚定在病毒膜上,具有长(~145个残基)
胞质尾Env是病毒表面唯一的病毒特异性分子,是宿主的主要靶点
中和抗体Env构象的灵活性对于病毒进入是必不可少的,并且也有助于病毒进入细胞内。
HIV-1逃避宿主抗体反应的能力。在病毒进入过程中,gp 120与受体的结合,
CD 4和CCR 5/CXCR 4,触发亚稳态Env的构象变化,最终导致gp 41-
介导的病毒和靶细胞膜的融合。病毒体上的HIV-1 Env可能至少
三种构象:“闭合的”预触发构象(状态1)、“开放的”CD 4结合构象(状态2)、“开放的”CD 4结合构象(状态3)和“开放的”CD 4结合构象(状态4)。
3),和一个中间的“部分开放”构象(状态2)。在受体接合之前,State-1 Env
构象在能量上是有利的,使得原代HIV-1菌株相对抵抗
潜在的中和抗体。CD 4结合驱动Env从状态1到状态2,然后进入状态3,
前发夹中间体。State-3 Env与CCR 5或CXCR 4共受体的结合促进了
的高度稳定的gp 41六螺旋束,导致病毒和靶细胞膜的融合。
多个观察结果表明,State-1 Env构象是亚稳定的,并且容易被
改变Env序列或从膜环境中提取Env。事实上,稳定的可溶性
已经显示了gp 140三聚体或洗涤剂增溶的Env三聚体,其详细结构是可用的
采取状态2的构造!拟议的工作将解决我们目前不完整的理解
的State-1 Env构象。HIV-1尽管变异性很大,但它是如何维持一个State-1 Env
构象?我们先前已经表明,多个Env氨基酸残基的变化可以破坏
一级构象。在所提出的研究中,我们将鉴定天然多态性Env残基,当
改变,稳定功能状态-1构象。我们将评估状态1稳定和状态1
Env相互作用的不稳定变化决定了病毒表型。这些研究的一个重点将是
gp 41近膜外区(MPER)的构象与蛋白质表达之间的关系
Env胞外域的其余部分的构象。
State-1 Env构象的亚稳定性阻碍其在免疫过程中呈递给宿主免疫系统。
自然感染HIV-1和接种疫苗后。拟议的研究将为生产纯化的
HIV-1 Env三聚体稳定在State-1构象,这是广泛中和的主要靶标。
抗体和有效的小分子进入抑制剂。了解State-1 Env构象是如何
监管应加快Env导向疗法和疫苗的设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH G SODROSKI其他文献
JOSEPH G SODROSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH G SODROSKI', 18)}}的其他基金
Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein
HIV-1 包膜糖蛋白的 State-1 构象的富集
- 批准号:
10094191 - 财政年份:2019
- 资助金额:
$ 63.77万 - 项目类别:
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
通过打开 HIV-1 包膜以应对抗体攻击来减少病毒储存
- 批准号:
9258013 - 财政年份:2017
- 资助金额:
$ 63.77万 - 项目类别:
Reducing viral reservoirs by opening HIV-1 Env to antibody attack
通过打开 HIV-1 包膜以应对抗体攻击来减少病毒储存
- 批准号:
9889022 - 财政年份:2017
- 资助金额:
$ 63.77万 - 项目类别:
Conformational Landscape of the HIV-1 Envelope Glycoproteins
HIV-1 包膜糖蛋白的构象景观
- 批准号:
10394418 - 财政年份:2016
- 资助金额:
$ 63.77万 - 项目类别:
Conformational Landscape of the HIV-1 Envelope Glycoproteins
HIV-1 包膜糖蛋白的构象景观
- 批准号:
10248854 - 财政年份:2016
- 资助金额:
$ 63.77万 - 项目类别:
Conformational Landscape of the HIV-1 Envelope Glycoproteins
HIV-1 包膜糖蛋白的构象景观
- 批准号:
9220709 - 财政年份:2016
- 资助金额:
$ 63.77万 - 项目类别:
Broad-range Inhibitors of Human Immunodeficiency Virus Entry
人类免疫缺陷病毒进入的广泛抑制剂
- 批准号:
8327385 - 财政年份:2012
- 资助金额:
$ 63.77万 - 项目类别:
Broad-range Inhibitors of Human Immunodeficiency Virus Entry
人类免疫缺陷病毒进入的广泛抑制剂
- 批准号:
8460830 - 财政年份:2012
- 资助金额:
$ 63.77万 - 项目类别:
Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers
HIV-1 包膜糖蛋白三聚体的单粒子重建
- 批准号:
8836390 - 财政年份:2011
- 资助金额:
$ 63.77万 - 项目类别:
Single-particle Reconstruction of HIV-1 Envelope Glycoprotein Trimers
HIV-1 包膜糖蛋白三聚体的单粒子重建
- 批准号:
8260824 - 财政年份:2011
- 资助金额:
$ 63.77万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 63.77万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 63.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 63.77万 - 项目类别:














{{item.name}}会员




